Artiva Biotherapeutics, Inc. 4

Director Elaine K. Sorg received an option award for 16,250 shares of Artiva Biotherapeutics, Inc. common stock at an exercise price of $10.42 per share.

On September 10, 2026, director Elaine K. Sorg received a stock option award from Artiva Biotherapeutics, Inc. for 16,250 shares of common stock at an exercise price of $10.42 per share, with the option vesting in full on the earlier of September 10, 2027 or the date of the company’s 2027 annual stockholder meeting and expiring on September 9, 2036; following this grant, she beneficially owns 16,250 shares (all underlying this option).

Filing Facts

CIK

1817241

Ticker

ARTV

Form

4

Source Type

fda

Accession

0001193125-26-390540

Alert Tier

5